Pharmaceutical

Blockbuster potential drugs ruled the 2024 pipeline with 53% rise over 2023

GLP-1RAs were the big game changer, boosting average forecast sales and return on investment rates.

Mar 29, 2025 - 06:00
Blockbuster potential drugs ruled the 2024 pipeline with 53% rise over 2023
GLP-1RAs were the big game changer, boosting average forecast sales and return on investment rates.
Read the original article

Tags:

Previous Article

Ionis and Sobi agree on olezarsen commercialisation

Next Article

Oral Semaglutide Significantly Decreases Incidence of Heart Attacks and Strokes ...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

China NMPA approves Zai Lab-argenx’s efgartigimod alfa for gMG

China NMPA approves Zai Lab-argenx’s efgartigimod alfa ...

Jul 18, 2024

Opinion: The U.S. must raise federal alcohol taxes to address the alarming rise in alcohol use

Opinion: The U.S. must raise federal alcohol taxes to a...

Dec 21, 2023

STAT+: Biotech power broker John Maraganore offers advice to the next crop of entrepreneurs

STAT+: Biotech power broker John Maraganore offers advi...

Oct 18, 2023